BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10178672)

  • 1. In-process cell counts during preparation of platelet concentrates from buffy coats.
    Stampfli R; Schaller M; Schenker T; Frey-Wettstein M; Hauser SP; Nydegger UE
    Transfus Sci; 1997 Dec; 18(4):495-503. PubMed ID: 10178672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of the quality of hemoderivatives obtained using a buffy-coat extraction system with a top-and-bottom technique (Optipress II)].
    Hurtado C; Bonanad S; Soler MA; Mirabet V; Blasco I; Planelles MD; de Miguel A
    Sangre (Barc); 1999 Oct; 44(5):319-26. PubMed ID: 10618907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality analysis of blood components obtained by automated buffy-coat layer removal with a top & bottom system (Optipress (R)II).
    Hurtado C; Bonanad S; Soler Mf; Mirabet V; Blasco I; Planelles Mf; De Miguel A
    Haematologica; 2000 Apr; 85(4):390-5. PubMed ID: 10756365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated preparation of platelet concentrates from pooled buffy coats: in vitro studies and experiences with the OrbiSac system.
    Larsson S; Sandgren P; Sjödin A; Vesterinen M; Gulliksson H
    Transfusion; 2005 May; 45(5):743-51. PubMed ID: 15847664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vivo evaluation of random donor platelet concentrates from pooled buffy coats.
    Klüter H; Dörges L; Maass E; Wagner T; Bartels H; Kirchner H
    Ann Hematol; 1996 Aug; 73(2):85-9. PubMed ID: 8774617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
    Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
    Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.
    Bertolini F; Rebulla P; Riccardi D; Cortellaro M; Ranzi ML; Sirchia G
    Transfusion; 1989 Sep; 29(7):605-9. PubMed ID: 2773027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of a 12-hour, 22 degrees C holding period for buffy coats on the preparation of platelet concentrates stored in plasma.
    Boeri N; Saleun S; Pelissier E; Saleun JP; Aiach M; Rendu F
    Transfusion; 1994 Oct; 34(10):881-6. PubMed ID: 7940660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet concentrates in an additive solution prepared from pooled buffy coats. In vivo studies.
    Eriksson L; Shanwell A; Gulliksson H; Högman CF; Svensson LA; Kristensen J; Berg B
    Vox Sang; 1993; 64(3):133-8. PubMed ID: 8484245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of leukocyte-poor platelet concentrates via a short, hard spin of a pool of buffy coats.
    van Delden CJ; Faber RD; de Wit HJ; Smit Sibinga CT
    Vox Sang; 2000; 78(3):164-70. PubMed ID: 10838517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WBC content of platelet concentrates prepared by the buffy coat method using different processing procedures and storage solutions.
    de Wildt-Eggen J; Schrijver JG; Bins M
    Transfusion; 2001 Nov; 41(11):1378-83. PubMed ID: 11724981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet concentrates from buffy coats: improved conditions for preparation and evaluation in routine clinical use.
    Rebulla P; Bertolini F; Porretti L; Marangoni F; Smacchia C; Marconi M; Riccardi D; Sirelson V; Pappalettera M; Sirchia G
    Transfus Sci; 1993 Jan; 14(1):41-6. PubMed ID: 10148312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low leukocyte contamination without filtration by preparation of platelet concentrates in cylindrical bags with the buffy-coat method.
    Kostelijk EH; Loos JA; Veldman HA; de Korte D
    Vox Sang; 2000; 79(2):87-93. PubMed ID: 11054046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion of platelet concentrates--clinical evaluation of two preparations.
    Strindberg J; Berlin G
    Eur J Haematol; 1996 Oct; 57(4):307-11. PubMed ID: 8982294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separation of platelet concentrates (PC) from buffy coat (BC) using the bottom and top drainage (BAT) system.
    Kretschmer V; Biermann E; Loh H
    Beitr Infusionsther; 1990; 26():65-70. PubMed ID: 1703903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fully automated processing of buffy-coat-derived pooled platelet concentrates.
    Janetzko K; Klüter H; van Waeg G; Eichler H
    Transfusion; 2004 Jul; 44(7):1052-8. PubMed ID: 15225247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines in platelet concentrates prepared from pooled buffy coats.
    Klüter H; Müller-Steinhardt M; Danzer S; Wilhelm D; Kirchner H
    Vox Sang; 1995; 69(1):38-43. PubMed ID: 7483490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separation of centrifuged whole blood and pooled buffy coats using the new CompoMat G5: 3 years experience.
    Bontekoe IJ; van der Meer PF; Mast G; de Korte D
    Vox Sang; 2014 Aug; 107(2):140-7. PubMed ID: 24602034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet concentrates in an additive solution prepared from pooled buffy coats. 1. In vitro studies.
    Eriksson L; Högman CF
    Vox Sang; 1990; 59(3):140-5. PubMed ID: 2264316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of holding buffy coats 4 or 18 hours before preparing pooled filtered PLT concentrates in plasma.
    Pérez-Pujol S; Lozano M; Perea D; Mazzara R; Ordinas A; Escolar G
    Transfusion; 2004 Feb; 44(2):202-9. PubMed ID: 14962311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.